+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Coatings For Implants Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666280
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Medical Coatings For Implants Market is projected to reach USD 1.80 Billion in 2026. It is expected to continue growing at a CAGR of 9.41%, reaching USD 3.11 Billion by 2032.

Medical coatings for implants are engineered surface technologies applied to orthopedic, dental, cardiovascular, neurostimulation, spinal, and other implantable devices to improve biocompatibility, osseointegration, corrosion resistance, wear performance, infection control, and drug delivery. Demand is being shaped by the rising burden of musculoskeletal disorders, cardiovascular disease, diabetes-related complications, dental conditions, and age-associated degenerative conditions, alongside wider access to elective and reconstructive surgery. Materials such as hydroxyapatite, titanium plasma spray, bioactive ceramics, antimicrobial coatings, polymeric coatings, drug-eluting layers, and nanostructured surfaces are increasingly used to enhance implant performance and reduce revision risk. Regulatory expectations for implant safety, sterilization compatibility, extractables and leachables, biocompatibility, coating adhesion, particulate generation, and long-term durability continue to influence product development. Across the medical device value chain, manufacturers are prioritizing coatings that support faster healing, lower infection risk, improved implant fixation, and compatibility with minimally invasive procedures, while healthcare providers focus on clinical evidence, traceability, and lifecycle performance.

Transformative Shifts in the Implant Coatings Landscape

The medical implant coatings landscape is shifting from passive surface protection toward multifunctional, bioactive, and patient-responsive coating systems. Orthopedic and dental implants increasingly rely on surfaces that promote bone ongrowth and ingrowth, while cardiovascular and neurological implants require coatings that manage hemocompatibility, inflammation, electrical insulation, and controlled drug release. Antimicrobial coating innovation has accelerated as surgical site infections and biofilm formation remain major clinical concerns, especially for high-risk patients and long-dwell implants. At the same time, manufacturing is moving toward precision deposition methods, including plasma spraying, physical vapor deposition, electrochemical deposition, sol-gel processing, layer-by-layer assembly, additive manufacturing-compatible coatings, and nanoscale surface modification. Sustainability and supply chain resilience are also changing procurement decisions, with attention on critical raw materials, sterilization impacts, manufacturing waste, and regulatory documentation. The transition to value-based care is encouraging evidence-backed coating selection, where durability, reduced complications, and revision avoidance are prioritized over material novelty alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing medical coatings for implants by improving materials discovery, process optimization, quality control, and post-market performance analysis. Machine learning models can help identify promising coating chemistries and surface architectures by analyzing relationships among composition, roughness, porosity, wettability, mechanical strength, degradation behavior, protein adsorption, cell response, and microbial adhesion. In manufacturing, AI-enabled process monitoring supports tighter control of plasma spray parameters, coating thickness, adhesion strength, surface defects, and batch consistency. Computer vision and advanced analytics are strengthening inspection of microcracks, delamination, particulate formation, and surface contamination. In clinical and regulatory contexts, AI can assist in analyzing registry data, adverse event patterns, revision causes, imaging outcomes, and real-world evidence to identify how coated implants perform across patient groups. However, adoption of AI must remain aligned with validated datasets, explainable models, cybersecurity controls, regulatory traceability, and human oversight, particularly because implant coatings directly affect long-term patient safety.

Key Regional Insights

In Asia-Pacific, medical coatings for implants are supported by expanding surgical capacity, rapidly aging populations in countries such as Japan, South Korea, and China, growing dental and orthopedic procedure volumes, and policy initiatives that encourage domestic medical device manufacturing. Europe is shaped by stringent medical device regulations, high quality and safety expectations, aging demographics, and strong adoption of advanced surface technologies in orthopedic, dental, and cardiovascular applications, with clinical evaluation and post-market surveillance playing a central role in coated implant acceptance. North America remains highly influenced by rigorous regulatory pathways, established orthopedic and cardiovascular implant use, advanced hospital infrastructure, and strong emphasis on clinical evidence, post-market surveillance, and infection prevention. Latin America is advancing through improved access to private healthcare, rising trauma and dental implant procedures, and increasing demand for cost-effective coated implants, although reimbursement variability and import dependence remain important considerations. Africa presents a heterogeneous environment where demand is linked to trauma care, reconstructive surgery, and gradual healthcare infrastructure improvement, while affordability, specialist availability, and supply chain reliability remain central adoption factors. In the Middle East, investment in specialized hospitals, medical tourism, and high-acuity surgical services is creating opportunities for premium implant technologies, particularly in countries expanding orthopedic, dental, and cardiovascular care capacity.

Key Group Insights

NATO member countries, many of which overlap with advanced healthcare systems in North America and Europe, show demand patterns influenced by trauma care readiness, defense-related medical innovation, rehabilitation needs, and high standards for quality-assured implantable medical devices. G7 countries remain important for advanced clinical adoption due to mature reimbursement systems, specialist surgical networks, strong regulatory oversight, and strict performance expectations for long-term implant safety. BRICS economies combine large patient populations, rising surgical volumes, domestic manufacturing priorities, and increasing focus on affordable yet technically advanced implant solutions, creating a diverse environment for hydroxyapatite, titanium-based, polymeric, and antimicrobial coating platforms. The European Union is strongly shaped by harmonized regulatory requirements, clinical evaluation expectations, vigilance systems, and sustainability priorities, making documentation, biocompatibility evidence, and traceability essential for coated implant adoption. ASEAN countries are increasingly relevant for medical coatings for implants as healthcare infrastructure expands, medical tourism grows, and local device manufacturing capabilities improve in select economies, supporting demand for reliable orthopedic, dental, and trauma implants. The GCC is characterized by high healthcare investment, expanding tertiary care capacity, and preference for clinically validated premium implant technologies, with procurement often guided by international regulatory approvals and hospital quality standards.

Key Country Insights

China is expanding domestic medical device innovation, hospital capacity, and implant manufacturing, with strong demand for cost-effective and advanced coating solutions across orthopedic, dental, cardiovascular, and trauma applications. The United States is defined by advanced implant utilization, robust regulatory scrutiny, extensive orthopedic and cardiovascular procedure activity, and strong emphasis on infection reduction and real-world clinical performance. Japan’s aging population and high regulatory standards support adoption of precise, durable, and biocompatible implant coatings, particularly in orthopedic, dental, and cardiovascular care. India is driven by rising orthopedic, dental, cardiovascular, and trauma procedures, expanding private healthcare, and price-sensitive procurement that favors clinically reliable and scalable coating technologies. Germany is highly advanced in orthopedic, dental, and precision medical engineering, supporting interest in durable and biocompatible coating technologies with strong documentation. The United Kingdom emphasizes clinical outcomes, procurement efficiency, and evidence-based adoption under a centralized healthcare environment. Australia emphasizes quality assurance, clinical evidence, and access to advanced orthopedic and dental implants. France combines strong healthcare access with rigorous device assessment and demand for clinically validated implants. South Korea combines advanced hospital infrastructure, medical technology innovation, and strong dental and orthopedic procedure activity, making it a key country for high-performance implant coating applications. Italy and Spain both show substantial orthopedic and dental implant needs due to aging demographics and established specialist care networks. Canada benefits from established public healthcare systems and high standards for device evaluation, with adoption influenced by hospital procurement, clinical guidelines, and cost-effectiveness evidence. Russia has demand across trauma and orthopedic care, with localization and supply chain resilience influencing sourcing. Brazil is a leading Latin American adopter, with demand tied to trauma, orthopedic reconstruction, dental implants, and domestic regulatory requirements. Mexico is supported by growing private healthcare, dental care demand, and medical tourism, while access and pricing remain important adoption factors.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated coating platforms that address proven unmet needs, including infection prevention, osseointegration, wear reduction, corrosion resistance, hemocompatibility, and controlled drug release. Development programs should integrate biocompatibility testing, mechanical durability assessment, sterilization validation, extractables and leachables evaluation, particulate analysis, and coating adhesion data from the earliest design stages. Manufacturers should strengthen collaboration with surgeons, biomaterials scientists, regulatory specialists, and hospital procurement teams to align coating performance with real clinical workflows and reimbursement expectations. Investment in advanced process control, digital inspection, and AI-supported quality analytics can improve consistency and reduce manufacturing variation. Organizations should also build stronger post-market evidence strategies using registries, clinical follow-up, complaint analysis, and revision data to demonstrate long-term value. To improve resilience, leaders should qualify multiple suppliers for critical raw materials, monitor regulatory changes across regions, and design coatings compatible with scalable, validated, and environmentally responsible manufacturing processes.

Research Methodology

This executive summary is developed through a structured secondary research approach focused on verified and data-backed industry intelligence from public health agencies, regulatory authorities, clinical literature, standards organizations, medical device guidance documents, hospital procurement trends, and peer-reviewed biomaterials research. The analysis evaluates implant coating applications across orthopedic, dental, cardiovascular, neurological, spinal, and other implant categories, with attention to coating materials, deposition technologies, safety requirements, clinical performance indicators, and regional adoption conditions. Regulatory and technical considerations are assessed through recognized frameworks for biocompatibility, sterilization, quality management, risk management, and post-market surveillance. Regional, group, and country insights are synthesized from demographic trends, healthcare infrastructure indicators, surgical access patterns, medical device regulatory environments, and documented shifts in clinical practice. The methodology intentionally excludes market sizing, market share, and forecasting, focusing instead on qualitative and evidence-supported interpretation of the medical coatings for implants landscape.

Conclusion

Medical coatings for implants are becoming central to the performance, safety, and clinical value of next-generation implantable devices. The industry is moving beyond conventional protective layers toward multifunctional surfaces that support biological integration, reduce infection risk, enable drug delivery, and improve long-term durability. Regional adoption is shaped by healthcare infrastructure, regulatory expectations, demographics, surgical capacity, and affordability, while AI and advanced manufacturing are improving materials selection, process reliability, and quality assurance. Success in this sector will depend on the ability to combine scientific innovation with validated clinical evidence, regulatory readiness, scalable production, and post-market performance monitoring. Organizations that align coating design with patient outcomes, surgeon needs, and healthcare system priorities will be best positioned to advance safer and more effective implant technologies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Coatings For Implants Market, by Coating Type
7.1. Introduction
7.2. Bioactive Coatings
7.2.1. Calcium Phosphate Coatings
7.2.2. Bioactive Glass Coatings
7.3. Antibacterial Coatings
7.3.1. Silver Nanoparticle Coatings
7.3.2. Copper-Based Coatings
7.4. Drug-Eluting Coatings
7.5. Hydrophilic Coatings
7.6. Hydrophobic Coatings
7.7. Hemocompatible Coatings
8. Medical Coatings For Implants Market, by Material Type
8.1. Introduction
8.2. Polymer Coatings
8.2.1. Silicone
8.2.2. Parylene
8.2.3. Polyurethane
8.3. Metallic Coatings
8.3.1. Titanium
8.3.2. Silver
8.4. Ceramic Coatings
8.4.1. Hydroxyapatite
8.4.2. Zirconia
9. Medical Coatings For Implants Market, by Deposition Method
9.1. Introduction
9.2. Plasma Spray
9.3. Thermal Spray
9.4. Physical Vapor
9.5. Chemical Vapor
9.6. Electrophoretic
10. Medical Coatings For Implants Market, by Implant Type
10.1. Introduction
10.2. Orthopedic
10.3. Dental
10.4. Cardiovascular
10.5. Neurological
10.6. Ophthalmic
10.7. Cosmetic & Reconstructive
10.8. Urological
11. Medical Coatings For Implants Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Orthopedic Clinics
11.4. Dental Clinics
11.5. Ambulatory Surgical Centers
11.6. Research Institutes
12. Medical Coatings For Implants Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Medical Coatings For Implants Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Medical Coatings For Implants Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Accentus Medical Ltd.
16.2. Adhezion Biomedical, LLC
16.3. APS Materials, Inc.
16.4. AST Products, Inc.
16.5. Biocoat Incorporated
16.6. Biovac
16.7. CAM Bioceramics B.V.
16.8. Coatings2Go, Inc.
16.9. Covalon Technologies Ltd.
16.10. DOT GmbH
16.11. DSM Biomedical
16.12. Dymax Corporation
16.13. ENS Technology
16.14. Freudenberg Medical, LLC
16.15. Harland Medical Systems, Inc.
16.16. Himed LLC
16.17. Hydromer, Inc.
16.18. Lincotek Group S.p.A.
16.19. Master Bond Inc.
16.20. Materion Corporation
16.21. Medicoat AG
16.22. Oerlikon Metco AG
16.23. Orchid MPS Holdings, LLC
16.24. PPG Industries, Inc.
16.25. Precision Coating Company, Inc.
16.26. Sono-Tek Corporation
16.27. Specialty Coating Systems, Inc.
16.28. Surface Solutions Group, LLC
16.29. Surmodics, Inc.
16.30. TeroLab Surface Group
List of Figures
FIGURE 1. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOACTIVE COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOACTIVE COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOACTIVE COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CALCIUM PHOSPHATE COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CALCIUM PHOSPHATE COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CALCIUM PHOSPHATE COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOACTIVE GLASS COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOACTIVE GLASS COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOACTIVE GLASS COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIBACTERIAL COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIBACTERIAL COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIBACTERIAL COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SILVER NANOPARTICLE COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SILVER NANOPARTICLE COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SILVER NANOPARTICLE COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COPPER-BASED COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COPPER-BASED COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COPPER-BASED COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG-ELUTING COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG-ELUTING COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG-ELUTING COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HYDROPHILIC COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HYDROPHILIC COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HYDROPHILIC COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HYDROPHOBIC COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HYDROPHOBIC COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HYDROPHOBIC COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HEMOCOMPATIBLE COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HEMOCOMPATIBLE COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HEMOCOMPATIBLE COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL POLYMER COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL POLYMER COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL POLYMER COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SILICONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PARYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PARYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PARYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL METALLIC COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL METALLIC COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL METALLIC COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SILVER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SILVER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SILVER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CERAMIC COATINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CERAMIC COATINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CERAMIC COATINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HYDROXYAPATITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HYDROXYAPATITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HYDROXYAPATITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ZIRCONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ZIRCONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ZIRCONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PLASMA SPRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PLASMA SPRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PLASMA SPRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THERMAL SPRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THERMAL SPRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THERMAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PHYSICAL VAPOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PHYSICAL VAPOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PHYSICAL VAPOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CHEMICAL VAPOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CHEMICAL VAPOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CHEMICAL VAPOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ELECTROPHORETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ELECTROPHORETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ELECTROPHORETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ORTHOPEDIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ORTHOPEDIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ORTHOPEDIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DENTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DENTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DENTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEUROLOGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NEUROLOGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NEUROLOGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL OPHTHALMIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL OPHTHALMIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL OPHTHALMIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COSMETIC & RECONSTRUCTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COSMETIC & RECONSTRUCTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COSMETIC & RECONSTRUCTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL UROLOGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL UROLOGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL UROLOGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 133. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 140. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 166. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 167. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 168. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 169. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 170. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 171. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 173. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 174. AFRICA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 189. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 190. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 191. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 192. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 193. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 194. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 195. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 196. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 197. NATO MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 200. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 201. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 202. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 203. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 204. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 205. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 206. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 207. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 208. G7 MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 211. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 212. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 213. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 214. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 215. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 216. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 217. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 218. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 219. BRICS MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 232. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 233. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 234. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 235. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 236. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 237. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 238. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 239. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 240. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 241. ASEAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 243. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 244. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 245. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 246. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 247. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 248. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 249. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 250. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 251. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 252. GCC MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 254. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 255. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 256. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 257. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 258. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 260. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 261. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 262. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 263. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 264. CHINA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 277. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 278. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 279. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 280. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 281. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 282. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 283. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 284. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 285. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 286. JAPAN MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 288. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 289. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 290. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 291. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 292. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 293. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 294. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 295. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 296. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 297. INDIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 300. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 301. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 302. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 303. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 304. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 305. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 306. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 307. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 308. GERMANY MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 321. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 322. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 323. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 324. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 325. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MILLION)
TABLE 326. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY METALLIC COATINGS, 2018-2032 (USD MILLION)
TABLE 327. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, 2018-2032 (USD MILLION)
TABLE 328. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY DEPOSITION METHOD, 2018-2032 (USD MILLION)
TABLE 329. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 330. AUSTRALIA MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. FRANCE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 332. FRANCE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY COATING TYPE, 2018-2032 (USD MILLION)
TABLE 333. FRANCE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY BIOACTIVE COATINGS, 2018-2032 (USD MILLION)
TABLE 334. FRANCE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY ANTIBACTERIAL COATINGS, 2018-2032 (USD MILLION)
TABLE 335. FRANCE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 336. FRANCE MEDICAL COATINGS FOR IMPLANTS MARKET SIZE, BY POLYMER COATINGS, 2018-2032 (USD MIL

Companies Mentioned

  • Accentus Medical Ltd.
  • Adhezion Biomedical, LLC
  • APS Materials, Inc.
  • AST Products, Inc.
  • Biocoat Incorporated
  • Biovac
  • CAM Bioceramics B.V.
  • Coatings2Go, Inc.
  • Covalon Technologies Ltd.
  • DOT GmbH
  • DSM Biomedical
  • Dymax Corporation
  • ENS Technology
  • Freudenberg Medical, LLC
  • Harland Medical Systems, Inc.
  • Himed LLC
  • Hydromer, Inc.
  • Lincotek Group S.p.A.
  • Master Bond Inc.
  • Materion Corporation
  • Medicoat AG
  • Oerlikon Metco AG
  • Orchid MPS Holdings, LLC
  • PPG Industries, Inc.
  • Precision Coating Company, Inc.
  • Sono-Tek Corporation
  • Specialty Coating Systems, Inc.
  • Surface Solutions Group, LLC
  • Surmodics, Inc.
  • TeroLab Surface Group

Table Information